Filter Results:
(156)
Show Results For
- All HBS Web
(1,289)
- People (5)
- News (156)
- Research (926)
- Events (6)
- Multimedia (12)
- Faculty Publications (757)
Show Results For
- All HBS Web
(1,289)
- People (5)
- News (156)
- Research (926)
- Events (6)
- Multimedia (12)
- Faculty Publications (757)
Sort by
- 15 Dec 2024
- News
After Ozempic
these drugs, known as GLP-1 agonists, amounts to so much more than media buzz. In just a few years, they have ignited a wave of change that has transformed Novo Nordisk into Europe’s most valuable public company. The seismic shift is on track to continue reshaping the... View Details
- 01 Jun 2023
- News
Research Brief: The Best Medicine
As it turns out, innovation doesn’t benefit everyone equally, and a new study tries to understand how that plays out in the pharmaceutical R&D process in the United States. “The numbers are striking,” says Associate Professor Joshua... View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift from the worldwide View Details
Keywords: Anne Kavanagh
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
dating—all those things—to life in a way that consumers have never experienced before?’” “Julie is a content-first pharmaceutical company; we exist to help bridge the consumer’s understanding of how her body works and how these medicines... View Details
- 24 Oct 2016
- News
Health Care Pioneer Giusti Named McCance Senior Fellow at HBS
care, or engineering. Giusti currently serves as faculty cochair of the HBS-Kraft Precision Medicine Accelerator. She has more than two decades of experience in the pharmaceutical industry, having previously held senior positions at G. D.... View Details
Keywords: Susan Young
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created... View Details
- 01 Dec 1996
- News
New Releases
a competitive factor. In a three-year study of pharmaceutical and biotechnology firms, Pisano shows that the development of distinctive and superior process technologies can lower costs, improve quality, and increase flexibility. He... View Details
- 03 Dec 2024
- News
From One to Many
created with Ferrazzi Greenlight? When I went to HBS I was known as the guy who came out of manufacturing, having spent a number of years implementing Total Quality Management at a pharmaceutical company in Wilmington, Delaware. I reached... View Details
- 01 Oct 1998
- News
Going Against the Flow
500 automobile, chemical, and pharmaceutical companies that actually run businesses here. Those latter companies know the market and have done very well as a result. "If you're going to invest in emerging markets," he continues, "you also... View Details
Keywords: Dun Gifford, Jr.
- 01 Jun 2012
- News
The Power of Philanthropy
When their son Joey died of cystic fibrosis in 1986 at age 12, Kathy and Joe O’Donnell (MBA 1971) vowed to fight the disease. O’Donnell, at the time the president of the Boston Concessions Group, joined with Vertex Pharmaceuticals and the... View Details
- 24 Apr 2014
- News
Building a better India through business and philanthropy
Known for understanding opportunities ahead of the curve, Ajay Piramal (AMP 110, 1992) led his family’s business away from textiles to pharmaceuticals in the 1980s. “Our guiding principle has been to build businesses that deliver... View Details
- 13 Jul 2020
- News
Locally Grown
pharmaceutical machinery sector. With the natural beauty of the Rocky Mountains as a backdrop for his career decision, Fenwick-Smith became increasingly interested in climate change and what the business community could do to make a... View Details
Keywords: April White
- 01 Jan 2008
- News
Jeffrey R. Immelt, MBA 1982
protein biomarkers that have been identified as the precursor to Alzheimer’s disease. “There’s still no cure,” he observes, “but if you know that someone has the early signs of the disease and combine that with some of the new drugs the View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
the business world has an important leadership role to play in terms of closing the gap in health and other vital social issues," he says. When Ray Gilmartin joined Merck in June 1994 as president and CEO (he became chairman several months later), it was the first time... View Details
- 29 Sep 2022
- News
Securing a Resilient Future for Senegal
pharmaceutical sovereignty as key priorities,” Diagne explains. Senegal also wants to boost tourism now that many countries have reopened their borders. The tertiary sector, which took a strong hit through the pandemic, still accounts for... View Details
Keywords: Maureen Harmon
- 01 Dec 2003
- News
Alumni Luminaries Discuss Careers, Values with HBS Students
Internal Revenue Service. Senior advisor, The Carlyle Group. He upgraded technology and information systems and stressed customer service in a dramatic turnaround of the IRS. Daniel L. Vasella, M.D. (PMD 57, 1989), chairman and CEO of Novartis AG, the world’s... View Details
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
and CEO of Mediconsulting, Inc., spoke about creating a better model for business collaborations between biotech and pharmaceutical firms. Said Klietmann, the conference's biotechnology chair and a lecturer in pathology at Harvard Medical... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
approach not just to insurance and reimbursement, but also to the places where medical services are delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs... View Details
- 01 Apr 1999
- News
Q & A: Confronting New Technologies: When Doing Right Is Wrong
industries or certain segments of the pharmaceutical business. But in many other industries - financial services, education, and health care, for instance - this analytical model is proving extremely helpful in understanding what is... View Details
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International, a struggling U.S. View Details
Keywords: Garry Emmons